Wu K K
Vascular Biology Research Center and Division of Hematology, University of Texas-Houston Medical Center, 77030, USA.
Biochem Pharmacol. 1998 Mar 1;55(5):543-7. doi: 10.1016/s0006-2952(97)00342-0.
Aspirin and conventional nonsteroidal anti-inflammatory drugs are nonselective inhibitors of cyclooxygenase-1 (COX-1) and COX-2 enzymes. Two classes of selective COX-2 inhibitors: (1) sulfonamides, such as L-745,337, and (2) tricyclic methyl sulfone derivatives, such as SC58125, have been developed. X-ray crystal structures of COX-1 and COX-2 have provided valuable information regarding the structural basis for their COX-2 selectivity. These compounds have less gastrointestinal complications in animal experiments. Their clinical efficacy and side-effects are being evaluated. Salicylate has very weak activity against either COX isoform and yet possesses anti-inflammatory actions. Recent studies indicate that it suppresses the expression of genes involved in inflammation. These activities may provide a plausible explanation for the pharmacological dilemma and, furthermore, may represent novel mechanisms for controlling inflammation.
阿司匹林和传统非甾体抗炎药是非选择性的环氧化酶-1(COX-1)和环氧化酶-2(COX-2)酶抑制剂。已开发出两类选择性COX-2抑制剂:(1)磺酰胺类,如L-745,337,以及(2)三环甲基砜衍生物,如SC58125。COX-1和COX-2的X射线晶体结构为其COX-2选择性的结构基础提供了有价值的信息。这些化合物在动物实验中胃肠道并发症较少。它们的临床疗效和副作用正在评估中。水杨酸盐对任何一种COX同工酶的活性都非常弱,但仍具有抗炎作用。最近的研究表明,它能抑制参与炎症的基因的表达。这些活性可能为药理学困境提供一个合理的解释,此外,可能代表控制炎症的新机制。